Literature DB >> 8268230

Human ribosomal protein L4: cloning and sequencing of the cDNA and primary structure of the protein.

C Bagni1, P Mariottini, F Annesi, F Amaldi.   

Abstract

The cloning and sequencing of a cDNA for human ribosomal protein L4 is reported. The corresponding mRNA has a very short 5' untranslated region initiating with a sequence of 12 pyrimidines, characteristic of all vertebrate ribosomal protein mRNAs. The deduced amino acid sequence shows that human ribosomal protein L4 has 425 amino acid residues and a calculated molecular mass of 47,821 Da. Comparison with the homologous counterparts of Xenopus, Drosophila and yeast shows that this protein has a very conserved amino-terminus region and an extremely divergent carboxyl-terminus portion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268230     DOI: 10.1016/0167-4781(93)90017-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Crystal structure of ribosomal protein L4 shows RNA-binding sites for ribosome incorporation and feedback control of the S10 operon.

Authors:  M Worbs; R Huber; M C Wahl
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Growth-dependent and growth-independent translation of messengers for heterogeneous nuclear ribonucleoproteins.

Authors:  O Camacho-Vanegas; F Weighardt; C Ghigna; F Amaldi; S Riva; G Biamonti
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

3.  Resistance of ribosomal protein mRNA translation to protein synthesis shutoff induced by poliovirus.

Authors:  B Cardinali; L Fiore; N Campioni; A De Dominicis; P Pierandrei-Amaldi
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  A microsomal ATP-binding protein involved in efficient protein transport into the mammalian endoplasmic reticulum.

Authors:  T Dierks; J Volkmer; G Schlenstedt; C Jung; U Sandholzer; K Zachmann; P Schlotterhose; K Neifer; B Schmidt; R Zimmermann
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.